Sugi Predict

Sugi Predict / Compounds / SCHEMBL3019155

SCHEMBL3019155

SCHEMBL3019155

CCC(C)=CCCC(C)=O

nearest known ligand 0.47

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 1/20 0.45
▸ ATM Q13315 1/20 0.45
▸ POLB P06746 1/20 0.43
▸ ALDH1A1 P00352 5/20 0.43
▸ TDP1 Q9NUW8 1/20 0.43
▸ KMT2A Q03164 3/20 0.42
▸ FNTA P49354 3/20 0.39
▸ FNTB P49356 3/20 0.39
▸ KDM1A O60341 1/20 0.39
▸ MAPT P10636 3/20 0.38
▸ ALOX15 P16050 2/20 0.38
▸ MEN1 O00255 2/20 0.38
▸ CYP3A4 P08684 1/20 0.38
▸ UGT1A1 P22309 1/20 0.38
▸ SQLE Q14534 1/20 0.37
▸ NR1H4 Q96RI1 1/20 0.36
▸ TRPA1 O75762 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5188887 1.00 KDM4E (0.45) KDM4EATMPOLBALDH1A1TDP1
SCHEMBL3019152 1.00 KDM4E (0.45) KDM4EATMPOLBALDH1A1TDP1
SCHEMBL1298997 0.95 KMT2A (0.50) KDM4EATMPOLBALDH1A1KMT2A
SCHEMBL1298995 0.95 KMT2A (0.50) KDM4EATMPOLBALDH1A1KMT2A
SCHEMBL11280546 0.89 FNTA (0.40) KDM4EATMPOLBALDH1A1TDP1
SCHEMBL10663274 0.89 FNTA (0.40) KDM4EATMPOLBALDH1A1TDP1
SCHEMBL11546466 0.86 ALDH1A1 (0.39) KDM4EATMPOLBALDH1A1TDP1
SCHEMBL11546461 0.86 ALDH1A1 (0.39) KDM4EATMPOLBALDH1A1TDP1
SCHEMBL30724804 0.83 KDM4E (0.46) KDM4EATMPOLBALDH1A1KMT2A
SCHEMBL11141399 0.83 FNTA (0.44) KDM4EATMPOLBALDH1A1TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 154 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-120004806-A Functionalized alkaline ionic liquid compound, synthesis method thereof and application thereof in alkynylation reaction 山东新和成精化科技有限公司 2025-05-16 — — CN claimed
CN-119431127-B Preparation method of 6-methyl-5-octene-2-ketone 济南悟通生物科技有限公司 2025-04-25 — — CN claimed
CN-119608144-A Hydrotalcite-based composite oxide catalyst, preparation method and application thereof in alkynol preparation 山东新和成药业有限公司 2025-03-14 — — CN claimed
CN-119431127-A Preparation method of 6-methyl-5-octene-2-ketone 济南悟通生物科技有限公司 2025-02-14 — — CN claimed
US-20240308948-A1 ORGANIC TERTIARY OR QUATERNARY AMMONIUM SALTS AS CATALYSTS IN THE FORMATION OF GAMMA, DELTA-UNSATURATED KETONES DSM IP ASSETS B.V. (NL) 2024-09-19 — — US claimed
EP-4288404-A1 ORGANIC TERTIARY OR QUATERNARY AMMONIUM SALTS AS CATALYSTS IN THE FORMATION OF GAMMA, DELTA-UNSATURATED KETONES DSM IP Assets B.V. (NL) 2023-12-13 — — EP claimed
CN-116829528-A Organic tertiary or quaternary ammonium salts as catalysts in the formation of gamma, delta-unsaturated ketones 帝斯曼知识产权资产管理有限公司 2023-09-29 — — CN claimed
CN-113999096-B Method for synthesizing 6-methyl-5-octene-2-ketone by condensation hydrogenation 万华化学集团股份有限公司 2023-05-30 — — CN claimed
CN-113979847-B Method for synthesizing 6-methyl-5-octen-2-one by carbonyl-ene reaction 万华化学集团股份有限公司 2023-01-17 — — CN claimed
EP-3541774-B1 NOVEL USE OF PHENYL PHOSPHINIC ACID DSM IP ASSETS BV (NL) 2022-11-30 — — EP claimed
US-20100204083-A1 PROCESS FOR THE PREPARATION OF ETHYLGERANONITRILE BASF SE (DE) 2010-08-12 — — US claimed
EP-2173704-A2 PROCESS FOR THE PREPARATION OF ETHYLGERANONITRILE BASF SE (DE) 2010-04-14 — — EP claimed
US-7638658-B2 Ethynylation process DSM IP ASSETS B.V. (NL) 2009-12-29 — — US claimed
WO-2009013199-A2 PROCESS FOR THE PREPARATION OF ETHYLGERANONITRILE BASF SE (DE) 2009-01-29 — — WO claimed
EP-1532092-B1 ETHINYLATION PROCESS DSM IP ASSETS BV (NL) 2008-11-05 — — EP claimed
WO-2007080103-A2 PROCESS FOR THE PREPARATION OF ALKYNEDIOLS DSM IP ASSETS B.V. (NL) 2007-07-19 — — WO claimed
EP-1808426-A1 Process for the preparation of alkynediols DSMIP Assets B.V. (NL) 2007-07-18 — — EP claimed
US-20050240066-A1 Ethynylation process DSM IP ASSETS B.V. (NL) 2005-10-27 — — US claimed
EP-1532092-A1 ETHYNYLATION PROCESS DSM IP Assets B.V. (NL) 2005-05-25 — — EP claimed
WO-2004018400-A1 ETHYNYLATION PROCESS DSM IP ASSETS B.V. (NL) 2004-03-04 — — WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240308948-A1 ORGANIC TERTIARY OR QUATERNARY AMMONIUM SALTS AS CATALYSTS IN THE FORMATION OF GAMMA, DELTA-UNSATURATED KETONES KAT5, KCNAB1, EBP KDM4E 381/4885ATM 2487/4885POLB 755/4885
US-20050240066-A1 Ethynylation process ADH1A, ADH4, ADH1C KDM4E 2441/4885ATM 1252/4885POLB 856/4885
US-20100204083-A1 PROCESS FOR THE PREPARATION OF ETHYLGERANONITRILE CYP51A1, ESD, CYP3A4 KDM4E 997/4885ATM 2108/4885POLB 1668/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.